Takeda Pharmaceutical Company Limited
JPX: 4502.T0.00 n/a
+0.00%(+0.00)
Key facts
- Exchange
- Tokyo Stock Exchange
- Sector
- Healthcare
- Industry
- Drug Manufacturers - Specialty & Generic
- CEO
- Christophe Weber
- Employees
- 49,281
- Headquarters
- Tokyo, Japan
- IPO year
- 2000
- Market cap
- ¥8.2T
- Website
- https://www.takeda.com
Loading 4502…
Loading profile data…Frequently asked questions about 4502
What does Takeda Pharmaceutical Company Limited (4502.T) do?
Takeda Pharmaceutical Company Limited engages in the research, development, manufacture, marketing, and out-licensing of pharmaceutical products in Japan, the United States, Europe, Canada, Latin America, Russia, rest of Asia, and internationally. It offers pharmaceutical products in the areas of gastroenterology, rare diseases, plasma derived t...
Where does 4502.T trade?
Takeda Pharmaceutical Company Limited (4502.T) trades on the Tokyo Stock Exchange.
What sector is 4502.T in?
Takeda Pharmaceutical Company Limited (4502.T) operates in the Healthcare sector, specifically in the Drug Manufacturers - Specialty & Generic industry.
Who is the CEO of Takeda Pharmaceutical Company Limited?
Christophe Weber is the chief executive officer of Takeda Pharmaceutical Company Limited (4502.T).
Where is Takeda Pharmaceutical Company Limited headquartered?
Takeda Pharmaceutical Company Limited is headquartered in Japan.
Does 4502.T pay a dividend?
Yes — Takeda Pharmaceutical Company Limited (4502.T) paid a trailing twelve-month dividend of JPY 200.00 per share. Frequency and ex-dividend dates are tracked on the dividends tab.
When did 4502.T go public?
Takeda Pharmaceutical Company Limited (4502.T) completed its initial public offering in 2000.